BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28/12/2018

Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a draft guidance for industry on generic linaclotide oral capsules, entitled "Draft Guidance on Linaclotide." The draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for linaclotide oral capsules.

Source: Federal Register — Food and Drug AdministrationOpen original release →